Abbott Laboratories
ABT
#124
Rank
NZ$290.61 B
Marketcap
NZ$166.85
Share price
0.94%
Change (1 day)
-24.04%
Change (1 year)
Categories

Abbott Laboratories (ABT), (founding name: Abbott Alkaloid Company) is a global pharmaceutical company with around 73,000 employees in 150 countries. Abbott was founded in 1888 by Wallace C. Abbott (1857-1921) and is headquartered in Abbott Park, a northern suburb of Chicago, Illinois.

EPS for Abbott Laboratories (ABT)

EPS in 2026 (TTM): NZ$6.15

According to Abbott Laboratories's latest financial reports the company's current EPS (TTM) is NZ$6.40. In 2025 the company made an earnings per share (EPS) of NZ$6.65 a decrease over its 2024 EPS that were of NZ$13.70.

EPS history for Abbott Laboratories from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$6.15-7.51%
2025NZ$6.65-51.49%
2024NZ$13.70134.51%
2023NZ$5.84-23.23%
2022NZ$7.617.5%
2021NZ$7.0857.41%
2020NZ$4.5021.54%
2019NZ$3.7054.75%
2018NZ$2.39389.07%
2017NZ$0.49-71.01%
2016NZ$1.69-68.01%
2015NZ$5.2796.13%
2014NZ$2.69-8.64%
2013NZ$2.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.49 142.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$12.44 94.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.32-63.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.36-0.52%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Thermo Fisher Scientific
TMO
NZ$32.30 404.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Boston Scientific
BSX
NZ$4.25-33.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
NZ$4.31-32.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.31-1.35%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$12.32 92.60%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$6.89 7.70%๐Ÿ‡ฌ๐Ÿ‡ง UK